Tissue no-reflow despite full recanalization following thrombectomy for anterior circulation stroke with proximal occlusion: A clinical study
- PMID: 32960688
- PMCID: PMC8370008
- DOI: 10.1177/0271678X20954929
Tissue no-reflow despite full recanalization following thrombectomy for anterior circulation stroke with proximal occlusion: A clinical study
Abstract
Despite early thrombectomy, a sizeable fraction of acute stroke patients with large vessel occlusion have poor outcome. The no-reflow phenomenon, i.e. impaired microvascular reperfusion despite complete recanalization, may contribute to such "futile recanalizations". Although well reported in animal models, no-reflow is still poorly characterized in man. From a large prospective thrombectomy database, we included all patients with intracranial proximal occlusion, complete recanalization (modified thrombolysis in cerebral infarction score 2c-3), and availability of both baseline and 24 h follow-up MRI including arterial spin labeling perfusion mapping. No-reflow was operationally defined as i) hypoperfusion ≥40% relative to contralateral homologous region, assessed with both visual (two independent investigators) and automatic image analysis, and ii) infarction on follow-up MRI. Thirty-three patients were eligible (median age: 70 years, NIHSS: 18, and stroke onset-to-recanalization delay: 208 min). The operational criteria were met in one patient only, consistently with the visual and automatic analyses. This patient recanalized 160 min after stroke onset and had excellent functional outcome. In our cohort of patients with complete and stable recanalization following thrombectomy for intracranial proximal occlusion, severe ipsilateral hypoperfusion on follow-up imaging associated with newly developed infarction was a rare occurrence. Thus, no-reflow may be infrequent in human stroke and may not substantially contribute to futile recanalizations.
Keywords: Perfusion; arterial spin labeling; cerebral blood flow; cerebral infarction diaschisis; large vessel occlusion.
Conflict of interest statement
Figures



Similar articles
-
Persistent Tissue-Level Hypoperfusion (No-Reflow) Negates the Clinical Benefit of Successful Thrombectomy.Stroke. 2025 Jun;56(6):1451-1459. doi: 10.1161/STROKEAHA.124.049574. Epub 2025 Mar 31. Stroke. 2025. PMID: 40160088
-
A direct aspiration first-pass technique vs stentriever thrombectomy in emergent large vessel intracranial occlusions.J Neurosurg. 2018 Feb;128(2):567-574. doi: 10.3171/2016.11.JNS161563. Epub 2017 Apr 14. J Neurosurg. 2018. PMID: 28409731
-
Prevalence and Significance of Impaired Microvascular Tissue Reperfusion Despite Macrovascular Angiographic Reperfusion (No-Reflow).Neurology. 2022 Feb 22;98(8):e790-e801. doi: 10.1212/WNL.0000000000013210. Epub 2021 Dec 14. Neurology. 2022. PMID: 34906976
-
Early postischemic hyperperfusion: pathophysiologic insights from positron emission tomography.J Cereb Blood Flow Metab. 1999 May;19(5):467-82. doi: 10.1097/00004647-199905000-00001. J Cereb Blood Flow Metab. 1999. PMID: 10326714 Review.
-
A Retrospective Single-Center Case Series of Direct Aspiration Thrombectomy as First-Line Approach in Ischemic Stroke and Review of the Literature.J Stroke Cerebrovasc Dis. 2019 Mar;28(3):640-648. doi: 10.1016/j.jstrokecerebrovasdis.2018.11.004. Epub 2018 Dec 19. J Stroke Cerebrovasc Dis. 2019. PMID: 30579732 Review.
Cited by
-
Neutrophil dynamics and inflammaging in acute ischemic stroke: A transcriptomic review.Front Aging Neurosci. 2022 Dec 22;14:1041333. doi: 10.3389/fnagi.2022.1041333. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36620775 Free PMC article. Review.
-
Reperfusion measurements, treatment time, and outcomes in patients receiving endovascular treatment within 24 hours of last known well.CNS Neurosci Ther. 2023 Apr;29(4):1067-1074. doi: 10.1111/cns.14080. Epub 2023 Jan 4. CNS Neurosci Ther. 2023. PMID: 36601659 Free PMC article.
-
Evolution of endovascular therapy trials for basilar artery occlusion.J Cereb Blood Flow Metab. 2023 Nov;43(11):2005-2007. doi: 10.1177/0271678X231187174. Epub 2023 Jul 6. J Cereb Blood Flow Metab. 2023. PMID: 37409675 Free PMC article.
-
Neutrophil-derived cathelicidin promotes cerebral angiogenesis after ischemic stroke.J Cereb Blood Flow Metab. 2023 Sep;43(9):1503-1518. doi: 10.1177/0271678X231175190. Epub 2023 May 17. J Cereb Blood Flow Metab. 2023. PMID: 37194247 Free PMC article.
-
Role of intravenous alteplase on late lesion growth and clinical outcome after stroke treatment.J Cereb Blood Flow Metab. 2023 Nov;43(2_suppl):116-125. doi: 10.1177/0271678X231167755. Epub 2023 Apr 5. J Cereb Blood Flow Metab. 2023. PMID: 37017421 Free PMC article. Clinical Trial.
References
-
- Goyal M, Menon BK, van Zwam WH, et al.. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016; 387: 1723–1731. - PubMed
-
- Molina CA.Futile recanalization in mechanical embolectomy trials: a call to improve selection of patients for revascularization. Stroke 2010; 41: 842–843. - PubMed
-
- Savitz SI, Baron JC, Yenari MA, et al.. Reconsidering neuroprotection in the reperfusion era. Stroke 2017; 48: 3413–3419. - PubMed
-
- Baron J-C.Protecting the ischaemic penumbra as an adjunct to thrombectomy for acute stroke. Nat Rev Neurol 2018; 14: 325–337. - PubMed
-
- De Silva DA, Fink JN, Christensen S, et al.. Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET). Stroke 2009; 40: 2872–2874. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous